Faron defers EUR 161,000 interest payment due Oct. 2 on convertible bonds to Dec. 2
Bitget2026/09/30 06:03- Faron Pharmaceuticals Oyj deferred amortization payments due Oct. 2, 2026 on its First Tranche Bonds and Second Tranche Bonds held by HCM.
- Deferred principal totals EUR 1,400,000, comprising EUR 840,000 on the first tranche and EUR 560,000 on the second tranche.
- Repayment shifts to final maturity dates: April 2, 2028 for the first tranche, Dec. 2, 2028 for the second tranche.
- Interest due Oct. 2, 2026 was also deferred to Dec. 2, 2026; amounts are EUR 63,000 and EUR 98,000.
- No interest will accrue on the deferred interest; other bond terms remain unchanged.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Starbucks (SBUX.US) officially refutes rumors: clearly denies acquiring Chipotle (CMG.US), focuses on "Back to Starbucks" transformation strategy
Starbucks publicly clarified on Monday that the company has not acquired Chipotle Mexican Grill, putting an end to the previous acquisition rumors.
BlackRock increases allocation to short-term US Treasuries and lowers US stocks: "Rate hike bets have gone too far," high yields should be prioritized
BlackRock has turned bullish on U.S. Treasury bonds for the first time in six years, upgrading short-term bonds to overweight and downgrading U.S. equities to neutral, stating that rate hike expectations are excessive and it is time to lock in yields.
AstraZeneca (AZN.US) Relizumab's new indication is expected to be included in priority review
Relizumab is a blockbuster product under AstraZeneca, with global sales projected to reach 4.718 billions USD in 2025 (YOY +20.23%).
4 Big Bank Earnings to Watch This Week as Wall Street Turns Bullish
Crypto prices
More
